Fernando Martín‐Moro

952 total citations · 1 hit paper
12 papers, 488 citations indexed

About

Fernando Martín‐Moro is a scholar working on Oncology, Hematology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Fernando Martín‐Moro has authored 12 papers receiving a total of 488 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 5 papers in Hematology and 4 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Fernando Martín‐Moro's work include Acute Myeloid Leukemia Research (3 papers), COVID-19 and healthcare impacts (3 papers) and Acute Lymphoblastic Leukemia research (2 papers). Fernando Martín‐Moro is often cited by papers focused on Acute Myeloid Leukemia Research (3 papers), COVID-19 and healthcare impacts (3 papers) and Acute Lymphoblastic Leukemia research (2 papers). Fernando Martín‐Moro collaborates with scholars based in Spain, Greece and United Kingdom. Fernando Martín‐Moro's co-authors include Marie Christiane Vekemans, John C. Riches, Stephen Booth, Lydia Scarfò, Lisa K. Hicks, William A. Wood, Ioannis Mantzaris, Rushad Patell, Inna Y. Gong and Jérôme Razanamahery and has published in prestigious journals such as Blood, British Journal of Haematology and Frontiers in Oncology.

In The Last Decade

Fernando Martín‐Moro

11 papers receiving 484 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients

2020 330 citations Abi Vijenthira, Inna Y. Gong et al. Blood profile →

Peers

Fernando Martín‐Moro

ONCOL

HEMAT

GENET

NEURO

Jérôme Razanamahery France

Thomas Chatzikonstantinou Greece

Tuğçe Nur Yiğenoğlu Türkiye

Lohith Gowda United States

Ghada Elgohary Egypt

Jack Rodman United States

Sinem Namdaroğlu Türkiye

Tulio E. Rodriguez United States

Flavia Rosado United States

Sigrun Einarsdottir Sweden

Jérôme Razanamahery France

Fernando Martín‐Moro

247 ×0.8

ONCOL

255 ×0.8

40 ×0.5

HEMAT

42 ×0.8

GENET

34 ×0.7

NEURO

Citations per year, relative to Fernando Martín‐Moro Fernando Martín‐Moro (= 1×) peers Jérôme Razanamahery

Countries citing papers authored by Fernando Martín‐Moro

Since Specialization

Citations

This map shows the geographic impact of Fernando Martín‐Moro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fernando Martín‐Moro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fernando Martín‐Moro more than expected).

Fields of papers citing papers by Fernando Martín‐Moro

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fernando Martín‐Moro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fernando Martín‐Moro. The network helps show where Fernando Martín‐Moro may publish in the future.

Co-authorship network of co-authors of Fernando Martín‐Moro

This figure shows the co-authorship network connecting the top 25 collaborators of Fernando Martín‐Moro. A scholar is included among the top collaborators of Fernando Martín‐Moro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fernando Martín‐Moro. Fernando Martín‐Moro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Martín‐Moro, Fernando, Javier López‐Jiménez, José A. García‐Marco, & José A. García-Vela. (2024). Comparative Review of the Current and Future Strategies to Evaluate Bone Marrow Infiltration at Diffuse Large B-Cell Lymphoma Diagnosis. Diagnostics. 14(6). 658–658. 2 indexed citations

Martín‐Moro, Fernando, et al.. (2024). Survival after allogeneic transplantation according to pretransplant minimal residual disease and conditioning intensity in patients with acute myeloid leukemia. Frontiers in Oncology. 14. 1394648–1394648. 1 indexed citations

Martín‐Moro, Fernando, Juan Marquet, Miguel Piris‐Villaespesa, et al.. (2023). Patients with secondary acute myeloid leukemia undergoing allogeneic stem‐cell transplant have inferior outcomes than de novo acute myeloid leukemia regardless minimal residual disease level by flow cytometry. Hematological Oncology. 41(4). 753–761. 3 indexed citations

Rodríguez-Mora, Sara, Magdalena Corona, Montserrat Torres, et al.. (2022). Early Cellular and Humoral Responses Developed in Oncohematological Patients after Vaccination with One Dose against COVID-19. Journal of Clinical Medicine. 11(10). 2803–2803. 5 indexed citations

Martín‐Moro, Fernando, Juan Marquet, Miguel Piris‐Villaespesa, et al.. (2020). Survival study of hospitalised patients with concurrent COVID‐19 and haematological malignancies. British Journal of Haematology. 190(1). e16–e20. 96 indexed citations

Vijenthira, Abi, Inna Y. Gong, Thomas A. Fox, et al.. (2020). Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients. Blood. 136(25). 2881–2892. 330 indexed citations breakdown →

Vijenthira, Abi, Inna Y. Gong, Thomas A. Fox, et al.. (2020). Outcomes of Adult and Pediatric Patients with Hematologic Malignancies and COVID-19: A Systematic Review and Meta-Analysis of 1847 Patients. Blood. 136(Supplement 1). 39–41.

Alonso, Rafael, María‐Teresa Cedena, Adolfo Gómez‐Grande, et al.. (2019). Imaging and bone marrow assessments improve minimal residual disease prediction in multiple myeloma. American Journal of Hematology. 94(8). 853–861. 30 indexed citations

Muñoz, Gloria, David García‐Seisdedos, Miguel Piris‐Villaespesa, et al.. (2019). Early detection of lysosomal diseases by screening of cases of idiopathic splenomegaly and/or thrombocytopenia with a next‐generation sequencing gene panel. JIMD Reports. 51(1). 53–61. 6 indexed citations

10.

Martín‐Moro, Fernando, Miguel Piris‐Villaespesa, Juan Marquet, et al.. (2019). Bone marrow infiltration by flow cytometry at diffuse large B‐cell lymphoma NOS diagnosis implies worse prognosis without considering bone marrow histology. Cytometry Part B Clinical Cytometry. 98(6). 525–528. 8 indexed citations

11.

Cedena, María‐Teresa, Rafael Ríos, Javier López Jiménez, et al.. (2017). Maintenance Treatment with Lenalidomide for Multiple Myeloma Increases the Proportion of MRD Negative (Flow-/PET-CT-) Patients. Blood. 130. 3098–3098. 2 indexed citations

12.

Martín‐Moro, Fernando, et al.. (2014). INITIAL POPULATION SIZE ESTIMATION FOR A DIFFERENTIAL-EVOLUTION-BASED GLOBAL LOCALIZATION FILTER. International Journal of Robotics and Automation. 29(3). 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact